Skip to main content

Lassa Fever

6
Pipeline Programs
3
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
2
2
0
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
2100%
+ 5 programs with unclassified modality

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Alliance Pharmaceuticals
3 programs
1
1
favipiravirPhase 2/3Small Molecule1 trial
ARN-75039Phase 2
Non interventional researchN/A1 trial
Active Trials
NCT03655561Active Not Recruiting1,200Est. Dec 2025
NCT04907682Completed40Est. Nov 2022
Eppendorf
EppendorfGermany - Hamburg
2 programs
1
1
FavipiravirPhase 2/3Small Molecule
Ribavirin ivPhase 2
Inovio Pharmaceuticals
2 programs
2
INO-4500Phase 11 trial
INO-4500Phase 11 trial
Active Trials
NCT04093076Completed220Est. Oct 2022
NCT03805984Completed60Est. Oct 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Alliance Pharmaceuticalsfavipiravir
Inovio PharmaceuticalsINO-4500
Inovio PharmaceuticalsINO-4500
Alliance PharmaceuticalsNon interventional research

Clinical Trials (4)

Total enrollment: 1,520 patients across 4 trials

NCT04907682Alliance Pharmaceuticalsfavipiravir

Pharmacokinetics, Tolerability and Safety of Favipiravir Compared to Ribavirin for the Treatment of Lassa Fever

Start: Jul 2021Est. completion: Nov 202240 patients
Phase 2Completed
NCT04093076Inovio PharmaceuticalsINO-4500

Dose-ranging Study: Safety, Tolerability and Immunogenicity of INO-4500 in Healthy Volunteers in Ghana

Start: Jan 2021Est. completion: Oct 2022220 patients
Phase 1Completed
NCT03805984Inovio PharmaceuticalsINO-4500

Safety, Tolerability and Immunogenicity of INO-4500 in Healthy Volunteers

Start: May 2019Est. completion: Oct 202060 patients
Phase 1Completed
NCT03655561Alliance PharmaceuticalsNon interventional research

Lassa Fever Clinical Course and Prognostic Factors in Nigeria

Start: Apr 2018Est. completion: Dec 20251,200 patients
N/AActive Not Recruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.